Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...
They've done it again: Lua Brewing claimed the No.1 spot for best brewpub in the country in the USA TODAY 10BEST Readers' Choice Awards. When Lua topped the list in 2025, the staff there bought their ...
Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or after a platinum-based regimen CE Mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results